Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

References

• Fernandez-Mendoza J , He F , LaGrotte C , Vgontzas AN , Liao D , Bixler EO . Impact of the metabolic syndrome on mortality is modified by objective short sleep duration. J Am Heart Assoc . 2017;6(5). doi:10.1161/JAHA.117.005479
   Web of Science ®Google Scholar
• Harris M . The metabolic syndrome. Aust Fam Physician . 2013;42:524–527.23971058
   PubMedGoogle Scholar
• Moore JX , Chaudhary N , Akinyemiju T . Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012. Prev Chronic Dis . 2017;14:E24. doi:10.5888/pcd14.160287 28301314
   PubMed Web of Science ®Google Scholar
• El Brini O , Akhouayri O , Gamal A , Mesfioui A , Benazzouz B . Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. Diabetes Metab SyndrObes . 2014;7:341.
   Google Scholar
• Aboul Ella NA , Shehab DI , Ismail MA , Maksoud AA . Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipidol . 2010;4(3):185–195. doi:10.1016/j.jacl.2010.03.007 21122651
   PubMed Web of Science ®Google Scholar
• Abd Elaziz KM , Gabal MS , Aldafrawy OA , Abou Seif HA , Allam MF . Prevalence of metabolic syndrome and cardiovascular risk factors among voluntary screened middle-aged and elderly Egyptians. J Public Health (Bangkok) . 2015;37(4):612–617. doi:10.1093/pubmed/fdu097
   Web of Science ®Google Scholar
• Bahijri SM , Al Raddadi RM . The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia. Ther Adv Endocrinol Metab . 2013;4(2):51–59. doi:10.1177/2042018813483165 23626902
   PubMedGoogle Scholar
• O‘Neill S , O‘Driscoll L . Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev . 2015;16(1):1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Goguet-Rubio P , Klug RL , Sharma DL , et al. Existence of a strong correlation of biomarkers and miRNA in females with metabolic syndrome and obesity in a population of West Virginia. Int J Med Sci . 2017;14(6):543–553. doi:10.7150/ijms.18988 28638270
   PubMed Web of Science ®Google Scholar
• Trajkovski M , Hausser J , Soutschek J , et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature . 2011;474(7353):649–653. doi:10.1038/nature10112 21654750
   PubMed Web of Science ®Google Scholar
• Karolina S , Tavintharan S , Armugam A , et al. Circulating miRNA Profiles in Patients with Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2012;97(12):E2271–E2276.
   Google Scholar
• Grundy SM , Cleeman JI , Daniels SR , et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation . 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404 16157765
   PubMed Web of Science ®Google Scholar
• Jin H , Benyshek DC . The ¡°metabolic syndrome index¡±: a novel, comprehensive method for evaluating the efficacy of diabetes prevention programs. J Diabetes Mellitus . 2013;03(02):4. doi:10.4236/jdm.2013.32014
   Google Scholar
• Wang Y , Tsai P , Liao Y , Hsu C . Circulating microRNAs have a sex-specific association with metabolic syndrome. Biomed Sci . 2013;1:20–72.
   Google Scholar
• Deiuliis JA . MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes . 2015;40:88. doi:10.1038/ijo.2015.170
   Web of Science ®Google Scholar
• Karolina DS , Tavintharan S , Armugam A , et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab . 2012;97(12). E2271–E2276. doi:10.1210/jc.2012-1996
   Web of Science ®Google Scholar
• Prats-Puig A , Ortega FJ , Mercader JM , et al. Changes in circulating MicroRNAs are associated with childhood obesity. J Clin Endocrinol Metab . 2013;98(10). E1655–E1660. doi:10.1210/jc.2013-1496
   Web of Science ®Google Scholar
• Kochar Kaur K . An update on Microrna?s and metabolic regulation with future therapeutic potentials regarding diagnosis and treatment of obesity, metabolic syndrome and other related disorders. J Health Med Inform . 2015;06(02). doi:10.4172/2157-7420.1000184
   Google Scholar
• Duggineni D . Obesity Modulates microRNA Expression in the Visceral Adipose of Humans and Mice . The Ohio State University; USA, 2013.
   Google Scholar
• Deiuliis JA , Syed R , Duggineni D , et al. Visceral adipose MicroRNA 223 is upregulated in human and murine obesity and modulates the inflammatory phenotype of macrophages. PLoS One . 2016;11(11):e0165962. doi:10.1371/journal.pone.0165962 27812198
   PubMed Web of Science ®Google Scholar
• Cui X , You L , Zhu L , et al. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes. Metabolism . 2018;78:95–105. doi:10.1016/j.metabol.2017.09.006 28966078
   PubMed Web of Science ®Google Scholar
• Kim YJ , Hwang SH , Lee SY , et al. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev . 2011;21(10):1749–1760. 21988232
   PubMed Web of Science ®Google Scholar
• Patel PS , Buras ED , Balasubramanyam A . The role of the immune system in obesity and insulin resistance. J Obes . 2013;2013. doi:10.1155/2013/616193
   Google Scholar
• Yang Y , Ji C , Guo S , et al. The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways. Oncotarget . 2017;8(42):72835–72846. doi:10.18632/oncotarget.20427 29069829
   PubMedGoogle Scholar
• de Mello V , Ferreira VD, Pulkkinen L , Lalli M , Kolehmainen M , Pihlajamäki J , Uusitupa M . DNA Methylation in Obesity and Type 2 Diabetes. Annals of Medicine. 2014; 46(3):103–113.
   Google Scholar
• Yang G , Xiong G , Cao Z , et al. miR-497 expression, function and clinical application in cancer. Oncotarget . 2016;7(34):55900.27344185
   PubMedGoogle Scholar
• de Mello VDF , Pulkkinen L , Lalli M , Kolehmainen M , Pihlajamäki J , Uusitupa M . DNA methylation in obesity and type 2 diabetes. Ann Med . 2014;46(3):103–113. doi:10.3109/07853890.2013.857259 24779963
   PubMed Web of Science ®Google Scholar
• Xu J-W , Wang T-X , You L , et al. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS One . 2014;9(3):e92847. doi:10.1371/journal.pone.0092847 24667580
   PubMed Web of Science ®Google Scholar
• Flowers E , Aouizerat BE . MicroRNA associated with dyslipidemia and coronary disease in humans. Physiol Genomics . 2013;45(24):1199–1205. doi:10.1152/physiolgenomics.00106.2013 24170031
   PubMed Web of Science ®Google Scholar
• Butz H , Kinga N , Racz K , Patocs A . Circulating miRNAs as biomarkers for endocrine disorders. J Endocrinol Invest . 2016;39(1):1–10. doi:10.1007/s40618-015-0316-5 26015318
   PubMed Web of Science ®Google Scholar
• Hassan N , Zhao JT , Sidhu SB . The role of microRNAs in the pathophysiology of adrenal tumors. Mol Cell Endocrinol . 2017;456:36–43. doi:10.1016/j.mce.2016.12.011 28007658
   PubMed Web of Science ®Google Scholar
• Frey JL , Kim SP , Li Z , Wolfgang MJ , Riddle RC . beta-catenin directs long-chain fatty acid catabolism in the osteoblasts of male mice. Endocrinology . 2018;159(1):272–284. doi:10.1210/en.2017-00850 29077850
   PubMed Web of Science ®Google Scholar
• Rajan S , Puri S , Kumar D , et al. Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/beta-catenin pathway. Eur J Med Chem . 2018;143:1345–1360. doi:10.1016/j.ejmech.2017.10.034 29153558
   PubMed Web of Science ®Google Scholar
• Li S , Zhu J , Zhang W , et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation . 2011. doi:10.1161/CIRCULATIONAHA.110.012237
   Web of Science ®Google Scholar
• Ali SS , Kala C , Abid M , Ahmad N , Sharma US , Khan NA . Pathological microRNAs in acute cardiovascular diseases and microRNA therapeutics. J Acute Dis . 2016;5(1):9–15. doi:10.1016/j.joad.2015.08.001
   Google Scholar
• Badawy HK , Abo-Elmatty DM , Mesbah NM . Association between serum microRNA-605 and microRNA-623 expression and essential hypertension in Egyptian patients. Meta Gene . 2018;16:62–65. doi:10.1016/j.mgene.2018.01.011
   Web of Science ®Google Scholar
• Xiao J , Lin H , Luo X , Luo X , Wang Z . miR‐605 joins p53 network to form a p53: miR 605: mdm2 positive feedback loop in response to stress. Embo J . 2011;30(3):524–532. doi:10.1038/emboj.2010.347 21217645
   PubMed Web of Science ®Google Scholar